Document Detail


Primary cutaneous Hodgkin's lymphoma.
MedLine Citation:
PMID:  19817768     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cutaneous involvement in Hodgkin's lymphoma is an uncommon but well-recognized condition that usually occurs with advanced-stage disease. Primary cutaneous Hodgkin's disease (PCHD) is exceedingly rare, with only a few reported cases. We report a case of a man treated with combination systemic chemotherapy for PCHD, and review the available literature.
Authors:
M Mukesh; D Shuttleworth; P Murray
Related Documents :
19936608 - Low grade cerebellar t-cell lymphoma: a novel response to treatment; a case report.
11815868 - Cutaneous lymphoblastic lymphoma in children: report of six cases with precursor b-cell...
9250148 - The monoclonal antibody alk1 identifies a distinct morphological subtype of anaplastic ...
10786808 - Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the s...
21384298 - Spinal epidural abscess following epidural cannulation for flail chest analgesia: a cas...
15273618 - Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: ra...
Publication Detail:
Type:  Case Reports; Journal Article; Review     Date:  2009-10-10
Journal Detail:
Title:  Clinical and experimental dermatology     Volume:  34     ISSN:  1365-2230     ISO Abbreviation:  Clin. Exp. Dermatol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2010-01-08     Completed Date:  2010-08-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7606847     Medline TA:  Clin Exp Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  e673-5     Citation Subset:  IM    
Affiliation:
Departments of Clinical Oncology, Essex County Hospital, Colchester, UK. drmukesh12@doctors.net.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / administration & dosage,  therapeutic use*
Bleomycin / administration & dosage
Dacarbazine / administration & dosage
Doxorubicin / administration & dosage
Hodgkin Disease / drug therapy*,  pathology
Humans
Male
Middle Aged
Neoplasm Staging
Skin Neoplasms / drug therapy*,  pathology
Treatment Outcome
Vinblastine / administration & dosage
Chemical
Reg. No./Substance:
0/ABVD protocol; 11056-06-7/Bleomycin; 23214-92-8/Doxorubicin; 4342-03-4/Dacarbazine; 865-21-4/Vinblastine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A case of epidermolysis bullosa acquisita with unusual clinical features.
Next Document:  Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immuni...